Rituxan (rituximab) - Roche
methylprednisolone sodium succinate - Generic mfg.
Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Autonomic Instability and Focal Seizures Without Detectable Ovarian Teratoma. (PubMed, Cureus) - Oct 19, 2026 - "She was started on first-line treatment with IV methylprednisolone and IVIG, but persistent cognitive impairment prompted escalation to second-line treatment with rituximab. The patient eventually experienced gradual neurological recovery with immunotherapy and neurorehabilitation, ultimately regaining her independence and returning home. This case highlights autonomic dysfunction as a possible feature of anti-NMDAR encephalitis and the importance of early immunotherapy, even in patients without an identifiable tumor." 
Journal • Alzheimer's Disease • Cardiovascular • CNS Disorders • Cognitive Disorders • Epilepsy • Immunology • Mental Retardation • Oncology • Ovarian Cancer • Psychiatry
http://www.ncbi.nlm.nih.gov/pubmed/42892987
 
Mohiuddin Sharief; Pavithra Muthiah
 
Oct 19, 2026
 
Prev Next